PRN: Visiongain Report Researches Growth Opportunities Within the $235bn OTC Pharmaceutical Market

02/ott/2019 07:40:17 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Visiongain Report Researches Growth Opportunities Within the $235bn OTC Pharmaceutical Market

 
[02-October-2019]
 

- Global OTC Pharmaceutical Market Forecast 2019-2029

- Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others

LONDON, Oct. 2, 2019 /PRNewswire/ -- The global OTC Pharmaceuticals market is estimated to be $162.64bn in 2018 and is expected to grow at a CAGR of 6.5% during the forecast period.

Visiongain Logo

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 212-page Visiongain report you will receive 100 tables and 103 figures- all unavailable elsewhere.

The 212-page report provides clear detailed insight into the Global OTC Pharmaceutical market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

To request sample pages from this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/global-otc-pharmaceutical-market-forecast-2019-2029/#download_sampe_div

Report Scope

• Global OTC Pharmaceutical Market forecasts from 2019-2029

• This report breaks down the revenue forecast of the Global OTC Pharmaceutical by product:
• Analgesics
• Cough, cold and allergy products
• Dermatological products
• Gastrointestinal products
• Eye Care
• Smoking Cessation Aids
• Other products

Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and RoW

• This report provides individual revenue forecasts to 2029 for these regional and national markets:
• North America: the US, Canada, Mexico
• South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America
• Europe: Germany, France, the UK, Spain, Italy, Rest of Europe
• Asia-Pacific: China, Japan, ! India, Australia, Thailand, Rest of Asia-Pacific
• Rest of the World: Middle East, Africa, Other Countries

Each regional market is further broken down by product.

• Our study provides a SWOT analysis and Porter's Five Forces analysis of the Global OTC Pharmaceutical market

• This report discusses the leading companies in the Global OTC Pharmaceutical market
• Bayer AG
• Cipla, Inc.
• Daiichi Sankyo Co., Ltd
• GlaxoSmithKline (GSK) Consumer Care
• Johnson & Johnson
• Perrigo Company PLC
• Pfizer Inc.
• Procter & Gamble
• Reckitt Benckiser Group PLC
• Sanofi S.A

• Key Questions Answered by this Report:
• How is the OTC pharmaceuticals market evolving?
• What is driving and restraining the OTC pharmaceuticals market growth?
• What are the market shares of the leading segments within the OTC pharmaceuticals market in 2018?
• How will the leading products in the OTC pharmaceuticals market grow over the forecast period and how much revenue will they account for in 2029?
• Which therapies will be the main drivers of the overall market from 2018 to 2029?
• How will the market shares of the national markets change by 2029 and which geographical region will lead the market in 2029?
• Who are the leading OTC pharmaceuticals companies, and what are their prospects over the forecast period?
• What are the predictions for M&A activity, consolidation for existing players and the potential prospects for new market entrants?

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/global-otc-pharmaceutical-market-forecast-2019-2029/

Did you know that we also offer a report add-on service? Email sara.peerun@visiongain.com to discuss any customized research needs you may have.

Companies covered in the report include:

23andMe
Abbott Medical Optics
Achelios Therapeutics, Inc.
Acrux
Agrifen
AiPing Pharmaceutical
Akron Pharmaceuticals
Alka Seltzer Vitacilina
Allegiant Health
Alliance Boots
Alvogen pharmaceuticals company
American Health
AmerisourceBergen
Amol Pharmaceuticals Private Limited
Apotex
Arena Pharmaceuticals
Aspen Australia
Aspen Global Inc.
Aspirina
Astellas Pharma US, Inc.
AstraZeneca PLC
Bal Pharma ltd.
Bayer
BePharBel
Beximco Pharmaceuticals
Binnopharm
Biocartis Group NV
Biocon Ltd.
BioGaia
BionTech AG
Bliss GVS Pharma Ltd.
Boehringer Ingelheim
Bristol-Myres Squibb
Bukwang Pharm. Co., Ltd.
Canagen Pharmaceuticals, Inc.
Cardinal Health
Carlyle Group
Catalent Pharma Solutions
Celesio
China Resources
Chr. Hansen
Cialis
Cleveland Clinic
CoLuc! id Pharma ceuticals
CR Pharmaceutical
Crescent Pharma
Curis, Inc.
Daiichi Sankyo
Delavau Pharmaceutical Partners
Dihon Pharmaceutical Group Co Ltd.
Ducere Pharma
Eisai Co., Ltd.
Electrolit
Eli Lilly
FameWave Ltd.
Flamel
Fujifilm Kyowa Kirin Biologics Co. Ltd.
GCP Laboratories
Genomma Lab
GIC Holdings
Gilead Medicines
GSK
Guangzhou Pharmaceutical Company, Ltd.
Guardian Drug Company
Haplogen GmbH
Hiran Agroceuticals Private Limited
Hi-Tech Pharmaceuticals
Im Co., Ltd
iNova Pharmaceuticals
Insight
Integral Molecular, Inc.
Ion Labs
Jagdale Healthcare
Janssen Pharmaceuticals, Inc.
Johnson & Johnson
Juno Pharmaceuticals
Kowa
Lion
Lipa Pharmaceuticals
LNK International, Inc.
Marksans Pharma
Mayne Pharma
McKesson Corporation
MCP3
Mead Johnson Nutrition Company
Merck
Merck Seron
Moberg Pharma
Momenta Pharm! aceutical s, Inc.
Morphic Therapeutic
Mylan N.V.
Nektar Therapeutics
Nektar Therapeutics
NeoStrata Company, Inc.
Nepstar
Nexgen Pharma Inc.
Next
Nihon Eisai Co., Ltd.
Novartis JV
Olainfarm
Olive Healthcare
Omega Pharma Invest N.V.
Ono Pharmaceutical Co., Ltd.
ORJagdale Healthcare SL
ORSL
Pedialyte
Perrigo Company PLC
Pfizer
Phoenix
Procter & Gamble
ProPhase Labs, Inc.
Purzer Pharmaceutical Co., Ltd.
Ranir Global Holdings LLC
Reckitt Benckiser
Rohto
Sal de Uvas Picot
Samson Pharmaceuticals, Inc.
Sanofi
Sarvotham Care Limited
Sato
Sentiss Pharmaceuticals, LLC
Shanghai Pharmaceuticals
Sinopharm
Sterling Pharmaceutical
Suerox
Taisho
Takeda
Target
TB Alliance
Tempra
Teva
Theravance Biopharma, Inc.
Transgene SA
Trividia Manufacturing Solutions, Inc.
TSI PharmaceuticalsValenta Pharm
Verily Life Sciences LLC
Vifor Pharma
Vista Pharmaceuticals
Walmart
Wellona Pharma

List of Organisations Mentioned in the Report
ANVISA
Association of the European Self-Medication Industry
Canadian Institute for Health Information
Center for Drug Evaluation and Research
European Medicines Agency
French Ministry of Health
Kyoto University
MD Anderson Cancer Center
Medicines and Healthcare products Regulatory Agency
Ministry of Health, Labour and Welfare
Pharmaceutical and Medical Devices Agency
Sarah Cannon Research Institute
State Food and Drug Administration

To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com

Related reports:

Global Antifungal Drugs Market Forecast 2019-2029

Indian Pharmaceutical Market Forecast 2019-2029

Global Antibacterial Drugs Market 2019-2029

Dermatological Drugs Market Forecast 2018-2028

Top 30 Pharmaceutical Wholesale & Distribution Organizations 2019 

Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl